Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

44806 ARTÍCULOS , VIENDO DEL 241 AL 255

BAX, VDAC, Gasdermin, and Permeability Transition Pores in Inflammatory Mitochondrial DNA Release: Is This the "Hole" Story?

Zhang N, Freeman DD, Polster BM.

Cells. 2026 Oct 10;15(20):1839. doi: 10.3390/cells15201839.

Dopamine Metabolism as a Chemically Constrained Network: Structural Regulation, Redox Liability and Dopaminergic Vulnerability in Parkinson's Disease

Ortega-Robles E, Guerra-Crespo M, Arias-Carrión O.

Med Sci (Basel). 2026 Sep 27;14(6):608. doi: 10.3390/medsci14060608.

Differential Temporal Dynamics and Motor-Non-Motor Dissociation After Inhaled Levodopa in Parkinson's Disease: A Post Hoc Analysis of the INLEVO-LIFE PD Study

Santos García D, Cerdán Sánchez M, Yáñez Baña R, Cabo I, Cimas Hernando MI.

Med Sci (Basel). 2026 Oct 17;14(6):680. doi: 10.3390/medsci14060680.

Translational Applications of Retinal Biomarkers in Chronic Cardiovascular, Neurological, Metabolic, and Renal Diseases

Capobianco M, Zeppieri M, Nicolosi SG, Castellino N, Cappellani F, Gattazzo I, Gagliano C.

Vision (Basel). 2026 Oct 9;10(4):78. doi: 10.3390/vision10040078.

Beyond a Single Mechanism: The iron-ROS-lipid Peroxidation Axis as a Central Driver of Prodromal Parkinson's Disease

Lyu P, Shen W, Wang Y, Chen X, Liu S, Zhang Y, A M, Jia X, Zhang M, Bu N, Wang S, Bai Y.

Mol Neurobiol. 2026 Oct 26;63(1):995. doi: 10.1007/s12035-026-06220-0.

TMEM175: Lysosomal Ion Channel Physiology, Therapeutic Potential, and Emerging Pharmacology

Li K, Le SD, Denton JS.

Am J Physiol Cell Physiol. 2026 Oct 19. doi: 10.1152/ajpcell.90012.2026. Online ahead of print.

Digital biomarkers derived from wearable and portable devices in prodromal Parkinson's disease and at-risk populations: a scoping review

Yu T, Wang Q, Pan M, Xiong Y, Hu S, Deng Y, Kuang L, Liu H.

Front Aging Neurosci. 2026 Oct 12;18:1850991. doi: 10.3389/fnagi.2026.1850991. eCollection 2026.

Supporting meaningful contributions of people affected by Parkinson's throughout the research process: Key considerations for inclusive patient and public involvement across the globe

Zeissler ML, McFarthing K, Bartlett M, Fothergill-Misbah N, Carroll CB, McArdle R.

J Parkinsons Dis. 2026 Oct 27:1877718X261502271. doi: 10.1177/1877718X261502271. Online ahead of print.

Brain-Computer Interfaces for Cognitive Rehabilitation: A Narrative Review

Cantillo-Negrete J, Rodríguez-García ME, Carrillo-Mora P, Méndez-Gómez DD, Carino-Escobar RI.

Bioengineering (Basel). 2026 Oct 19;13(10):1224. doi: 10.3390/bioengineering13101224.

Noninvasive Neuromodulation for Cognitive Dysfunction in Parkinson's Disease: A Scoping Review

Loftis SC, McClellan M, Sheridan AL, Rando C, O'Hara RB.

Brain Sci. 2026 Oct 9;16(10):1086. doi: 10.3390/brainsci16101086.

Prostaglandin E2 in Brain Inflammation: Roles and Dynamics

Nakanishi T, Fukuchi M.

Brain Sci. 2026 Oct 16;16(10):1118. doi: 10.3390/brainsci16101118.

NADPH Oxidase-Related Oxidative Stress in Parkinson's Disease-Associated Cognitive Impairment: An Evidence-Focused Review

Choi DH, Choi IA.

Antioxidants (Basel). 2026 Oct 21;15(10):1367. doi: 10.3390/antiox15101367.

The Sulfate-Reducing Bacteria Hypothesis in Parkinson's Disease: From Desulfovibrio-Derived Hydrogen Sulfide to Alpha-Synuclein Aggregation

Koterba M, Skiba A, Kler A, Błaszczyk K, Woźny M, Stefaniak O, Nowicka J.

Biomedicines. 2026 Oct 6;14(10):2256. doi: 10.3390/biomedicines14102256.

Peripheral Neuropathy in Parkinson's Disease Treated with Device-Assisted Therapies: How Often It Is Reported Depends on How It Is Sought. A Systematic Review and Meta-Analysis

Blidaru N, Tulbă D, Blidaru TC, Stoleru AM, Constantinescu AM, Popescu ME, Garofil DN, Popescu BO.

Biomedicines. 2026 Oct 8;14(10):2279. doi: 10.3390/biomedicines14102279.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias